{"slideshow_credits": null, "snippet": "Allergan made a small measure of peace with its would-be acquirers. | Calpers said it would eliminate all of its hedge fund investments. | Fielding strong demand, Alibaba Group raised the price range for its I.P.O. | Beer brewers could be...", "abstract": "Allergan made a small measure of peace with its would-be acquirers. | Calpers said it would eliminate all of its hedge fund investments. | Fielding strong demand, Alibaba Group raised the price range for its I.P.O. | Beer brewers could be contemplating another round of deal-making.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "William", "role": "reported", "lastname": "ALDEN", "rank": 1, "organization": ""}], "original": "By WILLIAM ALDEN"}, "web_url": "http://dealbook.nytimes.com/2014/09/16/morning-agenda-allergans-olive-branch/", "lead_paragraph": null, "headline": {"main": "Morning Agenda: Allergan's Olive Branch", "kicker": "DealBook"}, "_id": "541824f538f0d851fd3a8f9d", "word_count": "1672", "multimedia": [], "pub_date": "2014-09-16T07:53:39Z", "source": "The New York Times", "news_desk": "Business", "keywords": [], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}